Verisante Technology, Inc. Announces Submission to the FDA for Aura(TM), a Skin Cancer Detection Device

October 1, 2014 12:02 PM

3 0

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/01/14 -- Verisante Technology, Inc. (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, announced today it has initiated communications with the Food and Drug Administration ("FDA") in the United States for the approval of Aura™, a device for the detection of skin cancer.

"Verisante has now submitted documents to the FDA as we begin the formal application process for approval to market and sell Aura™ in the United States," said Thomas Braun. "We look forward to working closely with the FDA to receive further guidance and feedback on our regulatory pathway."

Read more

To category page

Loading...